Key Dates

Related Announcements

PAR-22-194 - NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)

NOT-HL-22-055 - Notice of Key Date Changes to NHLBI PAR-22-194 "NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)"

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to alert potential applicants to changes in Page Limitations for PAR-22-194 "NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)". Changes are shown in bold italics below.

Part 2. Full Text of Announcement

Section IV. Application and Submission Information

Current Language:

Page Limitations

All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed.

Revised language (in bold italics):

Page Limitations

All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed.

For this specific FOA, the Research Strategy section is limited to 12 pages, including tables, graphs, figures, diagrams, and charts.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries regarding this Notice to:

Scientific/Research Contact(s)

Pankaj Qasba, Ph.D.
National Heart, Lung and Blood Institute
Telephone: 301-435-0070
E-mail: qasbap@nhlbi.nih.gov

Jane Ye, Ph.D.
National Heart, Lung, and Blood Institute
Telephone: 301 480-7447
Email: jane.ye@nih.gov

Ye Yan, Ph.D.
National Heart, Lung, and Blood Institute
Telephone: 301-480-6779
Email: ye.yan@nih.gov